Abstract
The use of methamphetamine (METH) continues to increase the risk of human immunodeficiency virus (HIV) transmission within both homosexual and heterosexual drug abuser groups. Neurological studies indicate that the progression of HIV encephalitis is also enhanced by illicit drug use. Recently, the authors’ studies in the postmortem brains of HIV-positive METH users have shown that the combined effects of HIV and METH selectively damage calbindin (CB)-immunoreactive nonpyramidal neurons, which may contribute to the behavioral alterations observed in these patients. To better understand the mechanisms of toxicity associated with exposure to HIV and METH, neuronal survival, phenotypic markers, levels of oxidative stress, and mitochondrial potential were assessed in vitro in the hippocampal neuronal cell line, HT22, and in primary human neurons exposed to the HIV Tat protein and/or METH. Both Tat and METH were toxic to neurons in a time- and dose-dependent fashion. Neurons exposed to a combination of Tat and METH displayed early evidence of neuronal damage at 6 h, characterized by a decrease in CB and microtubuleassociated protein 2 (MAP2) immunoreactivity followed by more extensive cell death at 24 h. Loss of CB immunoreactivity associated with the combined exposure to Tat and METH was accompanied by mitochondrial damage with increased levels of oxidative stress. The toxic effects of Tat and METH were inhibited by blocking mitochondrial uptake of intracellular calcium, whereas blocking calcium flux in the endoplasmic reticulum or from the extracellular environment had no effect on Tat and METH toxicity. These studies indicate that in vitro, when combined, the HIV protein Tat and METH damage CB-immunoreactive nonpyramidal neurons by dysregulating the mitochondrial calcium potential. In combination, Tat and METH may increase cell injury and death, thereby enhancing brain metabolic disturbances observed in HIV-positive METH users in clinical populations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aksenov MY, Hasselrot U, Bansal AK, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM (2001). Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 305: 5–8.
Amano T, Matsubayashi H, Sasa M (2002). Alteration of neuronal activities following repeated administration of stimulants. Nihon Arukoru Yakubutsu Igakkai Zasshi 37: 31–40.
Bell JE, Brettle RP, Chiswick A, Simmonds P (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121(Pt 11): 2043–2052.
Berman SB, Hastings TG (1999). Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson’s disease. J Neurochem 73: 1127–1137.
Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, Schettini G (2001). HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 288: 301–308.
Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998). Variable progression of HIV-associated dementia. Neurology 50: 1814–1820.
Buckman JF, Hernandez H, Kress GJ, Votyakova TV, Pal S, Reynolds IJ (2001). MitoTracker labeling in primary neuronal and astrocytic cultures: influence of mitochondrial membrane potential and oxidants. J Neurosci Methods 104: 165–176.
Cadet JL, Brannock C (1998). Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32: 117–131.
Chesney MA, Barrett DC, Stall R (1998). Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health 88: 113–116.
Del Toro R, Levitsky KL, Lopez-Barneo J, Chiara MD (2003). Induction of T-type calcium channel gene expression by chronic hypoxia. J Biol Chem 278: 22316–22324.
Eisch A, O’Dell S, Marshall J (1996). Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse 22: 217–225.
Everall IP, Trillo-Pazos G, Bell C, Mallory M, Sanders V, Masliah E (2001). Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection. J Neuropathol Exp Neurol 60: 293–301.
Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M (2003). Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neurol 179: 60–70.
Griffiths EJ (2000). Use of ruthenium red as an inhibitor of mitochondrial Ca(2+) uptake in single rat cardiomyocytes. FEBS Lett 486: 257–260.
Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, Hauser KF (2001). Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 102: 555–563.
Hashimoto M, Sagara Y, Everall IP, Mallory M, Everson A, Langford D, Masliah E (2002). Fibroblast growth factor 1 regulates signaling via the GSK3{beta} pathway: implications for neuroprotection. J Biol Chem 277: 32985–32991.
Hesselgesser J, Horuk R (1999). Chemokine and chemokine receptor expression in the central nervous system. J NeuroVirol 5: 13–26.
Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, HorukR (1998). Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1alpha is mediated by the chemokine receptor CXCR4. CurrBiol 8: 595–598.
Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E (2000). α-Synuclein promotes mitochondrial deficiencies and oxidative stress. Am J Pathol 157: 401–410.
Huang M-B, Hunter M, Bond V (1999). Effect of extracellular human immunodeficiency virus Type 1 glycoprotein 120 on primary human vascular edothelial cell cultures. AIDS Res Human Retroviruses 15: 1265–1277.
Imam SZ, Ali SF (2000). Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res 855: 186–191.
Koller H, Schaal H, Freund M, Garrido SR, von Giesen HJ, Ott M, Rosenbaum C, Arendt G (2001). HIV-1 protein Tat reduces the glutamate-induced intracellular Ca2+ increase in cultured cortical astrocytes. Eur J Neurosci 14: 1793–1799.
Kruman II, Nath A, Mattson MP (1998). HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154: 276–288.
Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E, the HIV Neurobehavioral Research Center (2003). Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 34: 467–474.
Li HL, Roch J-M, Sundsmo M, Otero D, Sisodia S, Thomas R, Saitoh T (1997). Defective neurite extension is caused by a mutation in amyloid ß/A4 (Aß) protein precursor found in familial Alzheimer’s disease. J Neurobiol 32: 469–480.
Love S (1999). Oxidative stress in brain ischemia. Brain Pathol 9: 119–131.
Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R (1999). Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse 25: 475–493.
Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT (2002). Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31(Suppl 2): S62-S69.
Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR (2001). Acceleration of HIV dementia with methamphetamine and cocaine. J NeuroVirol 7: 66–71.
New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA (1998). HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-daspartate receptors by a NFkappaB-independent mechanism. J Biol Chem 273: 17852–17858.
Ohmori T, Abekawa T, Koyama T (1996). The role of glutamate in behavioral and neurotoxic effects of methamphetamine. Neurochem Int 29: 301–307.
Poot M, Zhang YZ, Kramer JA, Wells KS, Jones LJ, Hanzel DK, Lugade AG, Singer VL, Haugland RP (1996). Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. J Histochem Cytochem 44: 1363–1372.
Ramirez SH, Sanchez JF, Dimitri CA, Gelbard HA, Dewhurst S, Maggirwar SB (2001). Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependent mechanism. J Neurochem 78: 874–889.
Rego AC, Oliveira CR (2003). Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 28: 1563–1574.
Stephans S, Yamamoto B (1994). Methamphetamineinduced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17: 203–209.
Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ (1998). Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci 1: 366–373.
Tan S, Sagara Y, Liu Y, Maher P, Schubert D (1998). The regulation of reactive oxygen species production during programmed cell death. J Cell Biol 141: 1423–1432.
Taylor MJ, Alhassoon OM, Schweinsburg BC, Videen JS, Grant I (2000). MR spectroscopy in HIV and stimulant dependence HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 6: 83–85.
Turchan J, Anderson C, Hauser KF, Sun Q, Zhang J, Liu Y, Wise PM, Kruman I, Maragos W, Mattson MP, Booze R, Nath A (2001). Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2: 3.
Ying WL, Emerson J, Clarke MJ, Sanadi DR (1991). Inhibition of mitochondrial calcium ion transport by an oxobridged dinuclear ruthenium ammine complex. Biochemistry 30: 4949–4952.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by NIH grants MH59745, MH45294, MH58164, and DA12065, and a HNRC pilot project award. The HIV Neurobehavioral Research Center (HNRC) is supported by Center award MH 62512 from NIMH.
Rights and permissions
About this article
Cite this article
Langford, D., Grigorian, A., Hurford, R. et al. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. Journal of NeuroVirology 10, 327–337 (2004). https://doi.org/10.1080/13550280490520961
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280490520961